Target intelligence / Profile preview

Small hydrophobic protein of Respiratory Syncytial Virus subtype A (SH protein (RSV-A))

Target
SH protein (RSV-A)
Molecular classification
Viroporin (viral ion channel), Accessory protein, Type II transmembrane protein, Envelope protein (minor surface glycoprotein)
01

Overview

The small hydrophobic protein (SH) of Respiratory Syncytial Virus (RSV) subtype A is a minor surface glycoprotein encoded within the viral genome, consisting of approximately 64 amino acids in subgroup A[1][2]. It is a type II transmembrane protein with its ectodomain oriented extracellularly, concentrated at lipid rafts in the host cell membrane and the Golgi complex, and is only minimally present in the viral envelope[1][6]. The SH protein forms pentameric structures that function as ion channels (viroporins), potentially influencing membrane permeability and inhibiting host cell apoptosis, likely through TNF-α signaling inhibition[2][4][5]. Although non-essential for viral replication in vitro, deletion of the SH gene results in attenuation of RSV in animal models, supporting its role in pathogenesis but not viral entry or syncytium formation[1][2][3]. The full biological role of the SH protein remains partially characterized, and it is a less-established antiviral target compared to the fusion (F) and attachment (G) proteins of RSV[4].

Other names
SH proteinRSV SHSmall hydrophobic protein (RSV-A)Viroporin protein
02

Mechanism of action

(For theoretical inhibitors): Block SH-mediated ion channel/viroporin activity, destabilize viral assembly, or promote apoptosis in infected cells; experimental Inhibition of TNF-α pathway modulation None clinically validated

03

Biological functions

Forms pentameric ion channels (viroporin activity)Modulates membrane permeabilityDelays apoptosis in infected cells (inhibits TNF-α signaling)Contributes to viral infectivity and pathogenesis (attenuated viruses lacking SH)
04

Disease associations

Infection (RSV pathogenesis)Delays host cell apoptosis, prolonging viral replication cycleRSV-related lower respiratory tract disease, especially severe illness in infants and immunocompromised patients
05

Safety considerations

As SH is not essential for viral replication in vitro, targeting may have limited efficacyLack of clinical experience targeting SH means toxicity/safety profiles largely unknown
06

Interacting drugs

None directly approved or advanced for SH protein; most RSV drugs target the F and G proteins

1 more in the full profile.

07

Biomarkers

None validated for SH protein specifically; RSV viral load or identification of viral subtypes informs disease

Beyond the preview

Go deeper on Small hydrophobic protein of Respiratory Syncytial Virus subtype A (SH protein (RSV-A)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small hydrophobic protein of Respiratory Syncytial Virus subtype A (SH protein (RSV-A)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call